remodulin - treprostinil injection, solution
(Treprostinil)United Therapeutics Corporation
Usage: Remodulin treats pulmonary arterial hypertension (PAH; WHO Group 1) in adults with NYHA Class II–IV symptoms to reduce exercise-related symptoms. Also indicated for patients transitioning from epoprostenol to slow clinical deterioration.